EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thrombophilia and Folate Cycle Gene Polymorphisms in the Development of Ischemic Stroke After COVID-19

Dildora Khaydarova Kadirovna iD, Nodirjon Kadirovich Khaydarov, Sanobar Nizamovna Rakhmatova iD, Nilufar Kahhorovna Salomova iD, Visola Furkatovna Gaffarova iD, Qunduz Abdullo Qizi Sadulloyeva iD, Dilshod Izbilloyevich Sadullayev iD, Mukhammadjon Kahramon Ugli Berdiyev iD, Bakhodir Igamovich Djumayev iD, Nodirabegim Akbarovna Shukrulloeva iD, Ferangiz Shuxratovna Mukhamadieva iD, Ibodov Bekzod Abdusattotovich iD und 1 weitere

International Journal of Molecular Sciences · 13.03.2026 · 27 (6) · 2650

DOI: 10.3390/ijms27062650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2026. Verfasst von Dildora Khaydarova Kadirovna und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Medical Psychology, Tashkent State Medical University, Farabi Street 2, Tashkent 100109, Uzbekistan. Hauptthemen laut MEDLINE: COVID-19, Ischemic Stroke, Methylenetetrahydrofolate Reductase (NADPH2), Thrombophilia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 not only affects the respiratory system but also increases the risk of cerebrovascular complications, including ischemic stroke. Experimental and clinical data suggest that cytokine dysregulation and polymorphisms of thrombophilia-related genes (MTHFR, MTR, and MTRR) may jointly promote hypercoagulation, endothelial dysfunction, and thromboinflammation, thereby contributing to post-COVID ischemic stroke. This study included 160 patients treated at Zangiota Infectious Diseases Hospitals (2021–2023): 60 patients with ischemic stroke in the acute or post-COVID period (experiment group), 50 COVID-19 patients without ischemic stroke (comparison group), and 50 ischemic stroke patients without COVID-19 (control group). Clinical–neurological and immunological parameters were assessed, and polymorphisms in thrombophilia/folate cycle genes (MTHFR C677T, MTR, and MTRR) were genotyped by PCR/real-time PCR. Statistical analysis included χ2 tests, t-tests, logistic regression with odds ratios (OR) and 95% confidence intervals (CI); Hardy–Weinberg equilibrium was verified. A strong association was identified between the MTHFR C677T polymorphism and ischemic stroke on the background of COVID-19 (OR = 5.4; 95% CI: 2.1–13.8; p < 0.001). The TNF-α rs1800629 polymorphism was also significantly associated with COVID-19-related cerebrovascular events (OR = 3.27; 95% CI: 1.4–7.6; p = 0.006). Carriage of two or more minor alleles produced a synergistic effect, markedly increasing the risk of post-COVID ischemic stroke (OR = 5.59; 95% CI: 2.3–13.6; p < 0.001). These polymorphisms were linked to hyperhomocysteinemia, endothelial dysfunction, and mechanisms contributing to multifactorial arterial ischemic events. The combined assessment of thrombophilia and folate cycle-related genotypes and clinical indicators may provide a potential framework for improved risk stratification. Polymorphisms in MTHFR may appear to represent important genetic determinants of ischemic stroke following COVID-19, particularly in the context of arterial ischemic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Ischemic StrokeMethylenetetrahydrofolate Reductase (NADPH2)ThrombophiliaHumansFemaleMaleFolic AcidMiddle AgedAgedPolymorphism, Single NucleotideGenetic Predisposition to DiseaseSARS-CoV-2GenotypePolymorphism, Genetic

Stichwörter der Autor:innen

COVID-19folate cycle gene polymorphismshypercoagulation and inflammationischemic strokethrombophilia

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanFolic Acid

Autor:innen und Institutionen

  • Department of Neurology and Medical Psychology, Tashkent State Medical University, Farabi Street 2, Tashkent 100109, Uzbekistan.
  • Department of Neurology, Bukhara State Medical Institute, Gijduvan Street, 23, Bukhara 100100, Uzbekistan.

ORCID-Profile: Dildora Khaydarova Kadirovna, Sanobar Nizamovna Rakhmatova, Nilufar Kahhorovna Salomova, Visola Furkatovna Gaffarova, Qunduz Abdullo Qizi Sadulloyeva, Dilshod Izbilloyevich Sadullayev, Mukhammadjon Kahramon Ugli Berdiyev, Bakhodir Igamovich Djumayev, Nodirabegim Akbarovna Shukrulloeva, Ferangiz Shuxratovna Mukhamadieva, Ibodov Bekzod Abdusattotovich, Dilbar Tadjievna Khodjieva

Zitieren

APA

Kadirovna, D. K., Khaydarov, N. K., Rakhmatova, S. N., Salomova, N. K., Gaffarova, V. F., Sadulloyeva, Q. A. Q., Sadullayev, D. I., Berdiyev, M. K. U., Djumayev, B. I., Shukrulloeva, N. A., Mukhamadieva, F. S., Abdusattotovich, I. B., & Khodjieva, D. T. (2026). Thrombophilia and Folate Cycle Gene Polymorphisms in the Development of Ischemic Stroke After COVID-19. International Journal of Molecular Sciences, 27(6), 2650. https://doi.org/10.3390/ijms27062650

Vancouver

Kadirovna DK, Khaydarov NK, Rakhmatova SN, Salomova NK, Gaffarova VF, Sadulloyeva QAQ, et al. Thrombophilia and Folate Cycle Gene Polymorphisms in the Development of Ischemic Stroke After COVID-19. International Journal of Molecular Sciences. 2026;27(6):2650. doi:10.3390/ijms27062650

BibTeX
@article{Kadirovna2026,
  author = {Kadirovna, Dildora Khaydarova and Khaydarov, Nodirjon Kadirovich and Rakhmatova, Sanobar Nizamovna and Salomova, Nilufar Kahhorovna and Gaffarova, Visola Furkatovna and Sadulloyeva, Qunduz Abdullo Qizi and Sadullayev, Dilshod Izbilloyevich and Berdiyev, Mukhammadjon Kahramon Ugli and Djumayev, Bakhodir Igamovich and Shukrulloeva, Nodirabegim Akbarovna and Mukhamadieva, Ferangiz Shuxratovna and Abdusattotovich, Ibodov Bekzod and Khodjieva, Dilbar Tadjievna},
  title = {Thrombophilia and Folate Cycle Gene Polymorphisms in the Development of Ischemic Stroke After COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2650},
  doi = {10.3390/ijms27062650}
}
Kostenlos starten →